We utilized our multidisciplinary Brand Parenting™ approach to help enlarge and crystallize the vision for Symlin^® (pramlintide acetate) injection, building an identity and launch platform that positioned Symlin as a symbiotic brand with its own unique benefits independent of insulin. Once outside of the diabetes benchmark of A1C, we elevated the importance of glucose fluctuations and postprandial glucose as diabetes treatment targets. The launch detail aid represents the core element of this campaign.